NEW YORK–(BUSINESS WIRE)–Principal Asset Management® et Longevity Partners ont annoncé aujourd’hui le lancement de REsponsible Asset Solutions (RAS), une nouvelle plateforme qui aide les propriétaires immobiliers institutionnels à identifier, adopter et mettre en œuvre des initiatives de décarbonation permettant d’améliorer la performance des bâtiments, de réduire la consommation d’énergie et d’accroître la valeur à long terme des actifs, tout en atteignant les objectifs de rendement des inve
Month: September 2026
TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2026 Aide Memoire is available on the “Investors” page on its website.
Teva has compiled this document with public information that was previously provided by Teva in order to assist investors ahead of third quarter 2026 results, which are expected to be released on Tuesday, November 3, 2026, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET on the same day. This document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and the Aide Memoire document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, and in our Quarterly Report on Form 10-Q for the second quarter of 2026, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors” and “Forward-Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
Teva Media Inquiries
TevaCommunicationsNorthAmerica@tevapharm.com
Teva Investor Relations Inquiries
TevaIR@Tevapharm.com
TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2026 financial results on Tuesday, November 3, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.
In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.
A live webcast of the call will be available on Teva’s website at: https://ir.tevapharm.com/Events-and-Presentations.
Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This Document and the presentation at the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and to profitably commercialize our innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2026, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
Teva Media Inquiries
TevaCommunicationsNorthAmerica@tevapharm.com
Teva Investor Relations Inquiries
TevaIR@Tevapharm.com
FILADÉLFIA–(BUSINESS WIRE)–A Datavault AI Inc. (Nasdaq: DVLT) (“Datavault AI” ou a “Empresa”), uma empresa de Plataforma de Inteligência Artificial (“AIP”) que fornece tecnologias de monetização de dados, credenciamento e tokenização, anunciou hoje que seu conselho de administração (o “Conselho”) aprovou uma oferta de direitos de subscrição aos detentores de suas ações ordinárias (“Ações Ordinárias”) e de certos outros valores mobiliários da Datavault AI. A Moody Capital Solutions, Inc. (“Moo
NEW YORK–(BUSINESS WIRE)– #AIAgentSecuritySummit–Zenity was named a Market Shaper in Gartner’s inaugural Emerging Market Quadrant for AI Application Security, Startup Vendors.
CHRISTOPHER, Ill. & COLUMBUS, Ohio–(BUSINESS WIRE)–AndHealth announces first Illinois CHC partner as it enters its third state, bringing whole-person specialty care to medically underserved patients.
كولومبوس، أوهايو–(BUSINESS WIRE)–أعلنت illumynt، الشركة المتخصصة في إدارة دورة حياة التكنولوجيا والمدفوعة بالابتكار، والتي تقدم خدمات متقدمة تشمل التشخيص والإصلاح واستعادة المكونات والمعالجة الآمنة، اليوم عن توسعة عملياتها في منطقة كولومبوس لتصل مساحتها إلى نحو 200,000 قدم مربعة، ما يعزِّز بشكل كبير قدرتها على تلبية المتطلبات المتطورة والمتسارعة للبنية التحتية للذكاء الاصطناعي، ومراكز البيانات فائقة النطاق، ومصنّعي المعدات الأصلية، وبيئات تقنيات المؤسسات.وستوفر المنشأة الموسّعة طاقة استيعابية
CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas “Tommy” Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. Carls will report directly to Chairman and Chief Executive Officer, Pat Miles, and will serve as a member of ATEC’s Senior Leadership Team. In this newly created role, Carls will lead ATEC’
NEW YORK–(BUSINESS WIRE)–Principal Asset Management® en Longevity Partners kondigden vandaag de lancering aan van REsponsible Asset Solutions (RAS), een nieuw platform ontworpen om eigenaren van institutioneel vastgoed te helpen decarbonisatie-initiatieven te vinden, te onderschrijven en uit te voeren die de prestaties van gebouwen verbeteren, energieverbruik verminderen en de waarde van activa op lange termijn verhogen, terwijl ze ook voldoen aan de doelstellingen op het vlak van beleggingsr
WINTER PARK, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29, 2026.
Company Webcast
The webcast presentation will take place at 3:30 p.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/E2lpqML7me1. The webcast will also be available for replay following the event on the company’s website at https://ir.streamex.com/news-events/events.
1×1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/fall2026invreg/.
About Streamex Corp.
Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.
For more information, visit www.streamex.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, product development, and participation in the Lytham Partners Fall 2026 Investor Conference. These statements are based on current expectations and assumptions subject to risks and uncertainties beyond Streamex’s control, and actual results may differ materially, including as a result of market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update any forward-looking statements except as required by law.
Contacts
| Laura Kiernan | Henry McPhie |
| Head of Investor Relations, Streamex Corp. | Chief Executive Officer, Streamex Corp. |
| IR@streamex.com | 1-914-598-7733 | www.streamex.com | X.com/streamex |
